Comparison of Two Analgesic Strategies After Scheduled Caesarean

Comparison of Two Analgesic Strategies After Scheduled Caesarean : Block of the Lumbar Region With Ropivacaine Versus Intrathecal Morphine

To demonstrate the superiority of square lumbar block to ropivacaine compared to intrathecal morphine in the efficacy of postoperative analgesia following scheduled caesarean.

Study Overview

Detailed Description

Interventional, comparative, randomized, controlled study versus reference therapeutic strategy, in 2 parallel groups, double-blind (patient and evaluator), single-center, aiming to demonstrate the superiority of ropivacaine in square lumbar block versus intrathecal morphine, on the efficacy of post-operative analgesia, following a scheduled caesarean.

Study Type

Interventional

Enrollment (Actual)

104

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Quincy-sous-Sénart, France, 91480
        • MAUPAIN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient to undergo a scheduled caesarean under spinal anesthesia, for the birth of a term baby with a Pfannenstiel-type incision;
  • Patient in good health ;
  • Patient able to understand the information related to the study, read the information leaflet and agree to sign the consent form.

Exclusion Criteria:

  • Pregnancy less than 37 weeks with amenorrhea;
  • Multiple pregnancy;
  • Fetal pathology known at the time of inclusion;
  • Body mass index> 45 kg / m²;
  • History of scoliosis or spine surgery;
  • History of chronic pain associated with taking opiates, neuropathic pain, neurological pathology;
  • Preoperative anemia (blood hemoglobin <9 g / dL);
  • Hypersensitivity to ropivacaine or other local anesthetics with amide bond;
  • Hypersensitivity to morphine or opioids;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ropivacaine in quadratum lumburum block 2
Ropivacaine will be administrated in perineural in quadratum lumburum block 2 after the caesarian.
Administration of different anesthesia drugs in accordance with the courant practice (mixture of bupivacaine and sufentanil)
Other Names:
  • Bupivacaine and sufentanil
Morphine via pump (patient controlled analgesia)
Other Names:
  • injection of morphine
Active Comparator: Intrathecal morphine
Morphine will be administrated in intrathecal
Administration of different anesthesia drugs in accordance with the courant practice (mixture of bupivacaine and sufentanil)
Other Names:
  • Bupivacaine and sufentanil
Morphine via pump (patient controlled analgesia)
Other Names:
  • injection of morphine
Subcutaneous injection of Sodium chloride at the usual quadratum lumburum block 2 (QLB2) injection site under ultrasound ("sham-QLB2").
Other Names:
  • sham-QLB2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cumulative quantity of morphine received postoperatively via pump
Time Frame: 1 day
The main objective of the study is to demonstrate the superiority of square lumbar block to ropivacaine (quadratum lumburum block 2 - QLB2) in comparison to intrathecal morphine in the efficacy of postoperative analgesia following a scheduled Caesarean.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characteristics of postoperative pain using a visual analogic scale
Time Frame: 2 days
Evaluate the characteristics of postoperative pain in both groups with the use of a visual analog scale
2 days
Side effects of the two analgesic strategies
Time Frame: 2 days
Evaluate the side effects of the two analgesic strategies reported in a case report form
2 days
Cumulative quantity of morphine received postoperatively via pump
Time Frame: 2 days
Demonstrate the superiority of square lumbar block to ropivacaine (quadratum lumburum block 2 - QLB2) in comparison to intrathecal morphine in the efficacy of postoperative analgesia following a scheduled Caesarean.
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 22, 2021

Primary Completion (Actual)

October 12, 2022

Study Completion (Actual)

October 12, 2022

Study Registration Dates

First Submitted

February 8, 2021

First Submitted That Met QC Criteria

February 12, 2021

First Posted (Actual)

February 16, 2021

Study Record Updates

Last Update Posted (Actual)

August 5, 2024

Last Update Submitted That Met QC Criteria

August 1, 2024

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Subscribe